Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 8,588 | 11,649 | 11,197 | 8,667 | 9,637 |
| Cost of Goods | 1,528 | 2,154 | 2,166 | 1,669 | 1,382 |
| Gross Profit | 7,060 | 9,496 | 9,031 | 6,998 | 8,255 |
| Operating Expenses | 10,040 | 10,553 | 10,036 | 9,348 | 9,295 |
| Operating Income | -2,452 | -903 | -839 | -1,681 | -658 |
| Interest Expense | 18 | 22 | 9 | 30 | 32 |
| Other Income | 83 | 83 | 95 | 70 | 53 |
| Pre-tax Income | -2,388 | -843 | -753 | -1,641 | -637 |
| Income Tax | 4 | -21 | 4 | 3,536 | 657 |
| Net Income Continuous | -2,392 | -822 | -757 | -5,177 | -1,294 |
| Minority Interests | -13 | -21 | -14 | -17 | -19 |
| Net Income | $-2,379 | $-801 | $-743 | $-5,161 | $-1,274 |
| EPS Basic Total Ops | -0.15 | -0.05 | -0.05 | -0.32 | -0.08 |
| EPS Basic Continuous Ops | -0.15 | -0.05 | -0.05 | -0.32 | -0.08 |
| EPS Diluted Total Ops | -0.15 | -0.05 | -0.05 | -0.32 | -0.08 |
| EPS Diluted Continuous Ops | -0.15 | -0.05 | -0.05 | -0.32 | -0.08 |
| EBITDA(a) | $-1,759 | $-230 | $-179 | $-1,028 | $4 |